Inspira achieves positive results of above 95% for preventing bloodstream infections

The ex-vivo testing demonstrated significant bacterial reduction for the innovative iv dressing technology aimed at preventing bloodstream infections in critical patients ra'anana, israel , feb. 11, 2025 /prnewswire/ -- inspira™ technologies oxy b.h.n. ltd. (nasdaq: iinn) ("inspira" or the "company"), a pioneer in breakthrough life-support technology, today announced positive initial results from its previously reported collaboration with ennocure medtech ltd.
IINN Ratings Summary
IINN Quant Ranking